AquaBounty Technologies (NASDAQ:AQB) Announces Earnings Results

AquaBounty Technologies (NASDAQ:AQB) announced its quarterly earnings results on Thursday. The company reported ($0.20) EPS for the quarter, Zacks reports.

AquaBounty Technologies Price Performance

Shares of NASDAQ AQB traded down $0.01 during trading on Thursday, hitting $0.95. The stock had a trading volume of 55,474 shares, compared to its average volume of 41,033. AquaBounty Technologies has a 12 month low of $0.61 and a 12 month high of $2.95. The company has a market capitalization of $4.89 million, a PE ratio of -1.14 and a beta of 1.36. The firm has a fifty day moving average of $0.94 and a two-hundred day moving average of $0.98.

Institutional Trading of AquaBounty Technologies

An institutional investor recently bought a new position in AquaBounty Technologies stock. Two Sigma Investments LP purchased a new stake in shares of AquaBounty Technologies, Inc. (NASDAQ:AQB) in the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 37,565 shares of the company’s stock, valued at approximately $84,000. Two Sigma Investments LP owned 0.97% of AquaBounty Technologies as of its most recent filing with the Securities & Exchange Commission. Institutional investors own 8.92% of the company’s stock.

AquaBounty Technologies Company Profile

AquaBounty Technologies, Inc is a biotechnology company focused on aquaculture innovation through the development and commercialization of genetically engineered fish. Its flagship product, AquAdvantage Salmon, is an Atlantic salmon strain enhanced with a growth hormone gene that enables faster growth and more efficient feed conversion compared with conventional farmed salmon. By integrating biotechnology into seafood production, AquaBounty aims to address global protein demand while reducing the environmental footprint associated with marine aquaculture.

Founded in 1991, AquaBounty is headquartered in Maynard, Massachusetts, and operates a state-of-the-art, land-based incubation and grow-out facility in Panama.